Von Willebrand Disease (vWD) Clinical Trials

10 recruitingLast updated: June 20, 2026

There are 10 actively recruiting von willebrand disease (vwd) clinical trials across 12 countries. Studies span Phase 2, Phase 3, Not Applicable, Phase 1. Top locations include London, United Kingdom, Little Rock, Arkansas, United States, Camperdown, Sydney, Australia. Updated daily from ClinicalTrials.gov.


Von Willebrand Disease (vWD) Trials at a Glance

10 actively recruiting trials for von willebrand disease (vwd) are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in London, Little Rock, and Camperdown. Lead sponsors running von willebrand disease (vwd) studies include Takeda, Hemab ApS, and Medical University of Vienna.

Browse von willebrand disease (vwd) trials by phase

Treatments under study

About Von Willebrand Disease (vWD) Clinical Trials

Looking for clinical trials for Von Willebrand Disease (vWD)? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Von Willebrand Disease (vWD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Von Willebrand Disease (vWD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 2

A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand Disease

Von Willebrand Disease (vWD)
Shanghai RAAS Blood Products Co., Ltd.24 enrolled9 locationsNCT07640893
Recruiting
Phase 3

A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

Von Willebrand Disease (vWD)
Takeda24 enrolled21 locationsNCT05582993
Recruiting
Not Applicable

Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease

Von Willebrand Disease (vWD)
University Hospital, Lille66 enrolled17 locationsNCT06651255
Recruiting

A Study of Bleeding and Treatment in Participants With Von Willebrand Disease

Von Willebrand Disease (vWD)Von Willebrand Disease (VWD), Type 2Von Willebrand Disease (VWD), Type 1+4 more
Hemab ApS200 enrolled17 locationsNCT06610201
Recruiting
Phase 3

Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)

Von Willebrand Disease (vWD)
Vega Therapeutics, Inc60 enrolled14 locationsNCT07115004
Recruiting

An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)

Von Willebrand Disease (vWD)
Takeda13 enrolled1 locationNCT07404644
Recruiting

Endothelial Colony-Forming Cells in Patients With VWD, AVWS and Healthy Subjects

Von Willebrand Disease (vWD)Acquired Von Willebrand Disease
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico48 enrolled1 locationNCT07358013
Recruiting
Phase 3

A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)

Von Willebrand Disease (vWD)
Takeda20 enrolled7 locationsNCT07129343
Recruiting
Phase 1Phase 2

A Study Assessing HMB-002 in Participants With Von Willebrand Disease

Von Willebrand Disease (vWD)Von Willebrand Disease (VWD), Type 2Von Willebrand Disease (VWD), Type 1
Hemab ApS108 enrolled4 locationsNCT06754852
Recruiting
Phase 2

Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand Disease

Von Willebrand Disease (VWD), Type 2
Medical University of Vienna6 enrolled1 locationNCT07273721